Noam Fischman serves as the Co-Chair of Polsinelli’s Mergers & Acquisitions Litigation Working Group, a task force dedicated to deal-related litigation. In this role, Noam helps to lead a core group of Polsinelli’s most experienced transaction litigators to develop tools for assessing litigating risk before it manifests, and in assessing the magnitude of those risks when they can be valued into a transaction.
Noam is a “go to” trial lawyer with extensive experience litigating a wide range of issues that clients face. Noam’s primary experience and focus is in the health care industry, but he enjoys applying the lessons learned from these matters to other industries as well. Noam has substantial experience litigating matters for clients in the life sciences, travel, and technology areas.
Irrespective of industry, Noam serves as a trusted guide leading clients through cases in federal and state courts, as well as government investigations and matters involving regulatory agencies. In addition to typical contract and business tort claims, Noam routinely advises clients on issues related to the False Claims Act, the Foreign Corrupt Practices Act, RICO, the Telephone Consumer Protection Act, trade secrets, employment-related litigation and related state laws, and litigation issues associated with the EB-5 foreign investor program. He drafts compliance programs and trains clients to comply with those programs and related laws.
Noam leverages his industry-specific knowledge and experience to provide clients with practical advice aimed at avoiding disputes before they arise. But, if disputes are unavoidable, Noam pivots to zealous, creative, and goal-oriented litigation strategies aimed at maximizing leverage for his clients while simultaneously seeking to minimize the impact of litigation on the client’s business.